№ lp_1_2_01921
File format: docx Character count: 25801 File size: 40 KB
This document outlines the guidelines and requirements for Medicare Advantage and Prescription Drug Plan organizations to submit their plan benefit packages (PBP) and formulary information for the contract year 2022. It is a regulatory document aimed at ensuring compliance with the Medicare Modernization Act and the Social Security Act.
Year: 2022
Region / City: United States
Theme: Medicare Advantage, Prescription Drug Plan, Health Policy
Document Type: Report
Institution / Organization: Centers for Medicare & Medicaid Services (CMS)
Author: Centers for Medicare & Medicaid Services (CMS)
Target Audience: Medicare Advantage and Prescription Drug Plan organizations, healthcare administrators, policy makers
Period of Validity: CY 2022
Approval Date: Not specified
Modification Date: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Supporting Statement for Paperwork Reduction Act Submissions CMS Plan Benefit Package (PBP) and Formulary CY 2018
Year: 2018
Region / city: United States
Subject: Medicare Advantage, Prescription Drug Plan, Medicare
Document Type: Supporting Statement
Organization / institution: Centers for Medicare & Medicaid Services (CMS)
Author: Centers for Medicare & Medicaid Services (CMS)
Target Audience: Medicare Advantage (MA) and Prescription Drug Plan (PDP) organizations
Period of validity: CY 2018 through CY 2019
Approval Date: Not specified
Date of amendments: Not specified
Topics: 2022CMS-R-262 0938-0763 PBP